Business Daily.
.
The Times Real Estate
A+ R A-
Title Filter 
Display # 
# Article Title Author Hits
801 Shareholder Alert: Bronstein, Gewirtz Grossman, LLC Announces Investigation of Repros Therapeutics, Inc. Australian Business 237
802 Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2013 Australian Business 411
803 Pharmagen Announces Clotamin® Now Available at CVS.com Australian Business 387
804 New Dental Associate Joins Oak Ridge Dental Office Australian Business 319
805 Esprit Wellness Adds Disc Therapy Australian Business 281
806 ChangeMed Goes National With New Executive Team Australian Business 305
807 Columbus Dentist Serves Community Through Work with Free and Reduced-Cost Medical Clinics Australian Business 266
808 2014 Top Dentist Brings Microscope Dentistry to the Eastside Seattle Area Australian Business 298
809 Santa Rosa Dental Office Upgrades its Technology for More Precise Surgical Planning and Outcomes Australian Business 230
810 Gardena Dental Group Treats 26,000Th Patient At Their Gardena Dental Office Australian Business 269
811 Anaheim Dentist Looks to Educate Community through Informative Oral Health Website Australian Business 293
812 OnRamp and CompliancePoint Partner to Help Companies Achieve HIPAA Compliance Australian Business 224
813 Univar Announces Distribution Agreement with Swati Spentose for Lidocaine Products Australian Business 346
814 Le Dr Rongxiang Xu s'apprête à révéler la manière dont les organes humains peuvent atteindre une auto-régénération, lors de la remise de sa récompense intern Australian Business 239
815 Emerging Molecular Imaging Methodologies that Hold Promise for Major Advances in Patient Care to be Highlighted at Advanced Molecular Imaging and Its Clinical Translation Course Australian Business 225
816 Dr. Rongxiang Xu wird während seiner Auszeichnung mit dem internationalen Golden Biatec 2013 erklären, wie sich menschliche Organe selbst regenerieren können Australian Business 251
817 L'agenzia Italiana del farmaco (AIFA) approva il rimborso in classe A per Zonegran® (zonisamide) nell'indicazione in monoterapia in adulti conepilessia parziale di nuova diagnosi Australian Business 223
818 Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013 Australian Business 216
819 Electrocardiography (ECG) Devices - Emerging Markets 2009-2015 Australian Business 297
820 Global Animal/Veterinary Vaccines Market - 2013 Report Australian Business 255

Page 41 of 96

Business Daily Media